Ensemble Capital Management LLC purchased a new stake in Trupanion Inc (NASDAQ:TRUP) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 183,580 shares of the financial services provider’s stock, valued at approximately $7,086,000. Trupanion accounts for 1.2% of Ensemble Capital Management LLC’s investment portfolio, making the stock its 20th biggest position. Ensemble Capital Management LLC owned about 0.56% of Trupanion at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. SG Americas Securities LLC acquired a new position in shares of Trupanion in the 2nd quarter valued at $100,000. First Mercantile Trust Co. acquired a new position in shares of Trupanion in the 2nd quarter valued at $142,000. US Bancorp DE lifted its stake in shares of Trupanion by 111.8% in the 2nd quarter. US Bancorp DE now owns 4,512 shares of the financial services provider’s stock valued at $175,000 after purchasing an additional 2,382 shares during the period. Xact Kapitalforvaltning AB acquired a new position in shares of Trupanion in the 2nd quarter valued at $224,000. Finally, S&CO Inc. acquired a new position in shares of Trupanion in the 2nd quarter valued at $232,000. 94.00% of the stock is currently owned by institutional investors.
In other Trupanion news, Director Murray B. Low sold 3,000 shares of Trupanion stock in a transaction dated Friday, August 10th. The stock was sold at an average price of $38.12, for a total value of $114,360.00. Following the sale, the director now owns 189,782 shares of the company’s stock, valued at approximately $7,234,489.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Darryl Rawlings sold 4,000 shares of Trupanion stock in a transaction dated Friday, August 24th. The shares were sold at an average price of $37.21, for a total value of $148,840.00. Following the completion of the sale, the insider now directly owns 1,289,989 shares in the company, valued at approximately $48,000,490.69. The disclosure for this sale can be found here. Insiders have sold a total of 23,450 shares of company stock worth $925,759 in the last ninety days. 20.70% of the stock is currently owned by company insiders.
A number of research analysts have recently weighed in on TRUP shares. Craig Hallum started coverage on Trupanion in a research note on Thursday, July 19th. They issued a “buy” rating and a $55.00 price target on the stock. Canaccord Genuity increased their price target on Trupanion from $40.00 to $46.00 and gave the company a “buy” rating in a research note on Friday, August 3rd. BidaskClub downgraded Trupanion from a “buy” rating to a “hold” rating in a research note on Tuesday, August 14th. Stifel Nicolaus increased their price target on Trupanion from $40.00 to $43.00 and gave the company a “buy” rating in a research note on Friday, August 3rd. Finally, Zacks Investment Research downgraded Trupanion from a “buy” rating to a “hold” rating in a research note on Saturday, August 18th. One analyst has rated the stock with a sell rating, two have issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $45.13.
Shares of Trupanion stock opened at $37.37 on Friday. The firm has a market cap of $1.25 billion, a P/E ratio of -533.86 and a beta of 0.58. Trupanion Inc has a 12 month low of $20.52 and a 12 month high of $46.70. The company has a debt-to-equity ratio of 0.16, a quick ratio of 3.04 and a current ratio of 3.04.
Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Thursday, August 2nd. The financial services provider reported ($0.01) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.05) by $0.04. The business had revenue of $73.39 million for the quarter, compared to the consensus estimate of $72.70 million. Trupanion had a negative return on equity of 4.43% and a negative net margin of 0.84%. The firm’s revenue was up 25.9% compared to the same quarter last year. During the same quarter last year, the business posted ($0.02) EPS. analysts expect that Trupanion Inc will post -0.09 EPS for the current year.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Further Reading: Trading Strategy Methods for Individual Investors
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion Inc (NASDAQ:TRUP).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.